Cell Growth & Differentiation, Vol 3, Issue 12 929-938, Copyright © 1992 by American Association of Cancer Research

ARTICLES

Nonuniform expression of a mouse mammary tumor virus-driven int-2/Fgf-3 transgene in pregnancy-responsive breast tumors

G Stamp, V Fantl, R Poulsom, S Jamieson, R Smith, G Peters and C Dickson
Histopathology Laboratory, Imperial Cancer Research Fund, London, United Kingdom.

We have developed transgenic mice in which expression of the mouse int-2/Fgf-3 gene is regulated by a single long terminal repeat from mouse mammary tumor virus. Such mice contain and transmit a replica of the activated int-2/Fgf-3 allele present in a spontaneous mammary tumor from a BR6 mouse. Although free of infectious mouse mammary tumor virus and with a different genetic background, the transgenic mice develop pregnancy-responsive mammary epithelial proliferations that are similar to the early stages of tumorigenesis in the BR6 strain. Histological examination revealed that most of these tumors showed pronounced tubular and acinar structures, features usually associated with morphological differentiation. In some cases, the tumors were locally invasive, causing disruption of the dermis which manifested itself as local hair loss. In situ hybridization showed that patterns of transgene expression in the abnormal glands were markedly nonuniform. In contrast, mouse mammary tumor virus-induced neoplasms showed more uniform expression of int-2/Fgf-3, as did the urogenital epithelial proliferations that occur among males of this transgenic line. These data suggest that mammary tumors in virally infected animals may depend primarily on autocrine stimulation by the int-2/Fgf-3 gene product, whereas both autocrine and paracrine mechanisms may contribute to tumors and hyperplasias found in transgenic animals.

This article has been cited by other articles:

				E. S. W. Ngan, Z.-Q. Ma, S. S. Chua, F. J. DeMayo, and S. Y. Tsai Inducible expression of FGF-3 in mouse mammary gland PNAS, August 20, 2002; 99(17): 11187 - 11192. [Abstract] [Full Text] [PDF]

				K. Reimers, M. Antoine, M. Zapatka, V. Blecken, C. Dickson, and P. Kiefer NoBP, a Nuclear Fibroblast Growth Factor 3 Binding Protein, Is Cell Cycle Regulated and Promotes Cell Growth Mol. Cell. Biol., August 1, 2001; 21(15): 4996 - 5007. [Abstract] [Full Text] [PDF]

				M. Antoine, M. Daum, R. Köhl, V. Blecken, M. J. Close, G. Peters, and P. Kiefer NH2-Terminal Cleavage of Xenopus Fibroblast Growth Factor 3 Is Necessary for Optimal Biological Activity and Receptor Binding Cell Growth Differ., November 1, 2000; 11(11): 593 - 605. [Abstract] [Full Text]

				B. R. Davies, A. M. Platt-Higgins, G. Schmidt, and P. S. Rudland Development of Hyperplasias, Preneoplasias, and Mammary Tumors in MMTV-c-erbB-2 and MMTV-TGF{alpha} Transgenic Rats Am. J. Pathol., July 1, 1999; 155(1): 303 - 314. [Abstract] [Full Text] [PDF]

				M. Antoine, K. Reimers, C. Dickson, and P. Kiefer Fibroblast Growth Factor 3, a Protein with Dual Subcellular Localization, Is Targeted to the Nucleus and Nucleolus by the Concerted Action of Two Nuclear Localization Signals and a Nucleolar Retention Signal J. Biol. Chem., November 21, 1997; 272(47): 29475 - 29481. [Abstract] [Full Text] [PDF]

				D Jackson, J Bresnick, I Rosewell, T Crafton, R Poulsom, G Stamp, and C Dickson Fibroblast growth factor receptor signalling has a role in lobuloalveolar development of the mammary gland J. Cell Sci., January 6, 1997; 110(11): 1261 - 1268. [Abstract] [PDF]